Gland Pharma Limited approved during the meeting of the Nomination and Remuneration Committee of the Board of Directors held on 25th March, 2024 as mentioned below: Mr. K.V.G.K. Raju would cease to be the Chief Technical Officer and Head of Quality of the Company with effect from the close of business hours on 29th March, 2024; due to his superannuation. Accordingly, Mr. K.V.G.K. Raju shall also cease to be Senior Management Personnel of the Company with effect from 30th March, 2024. Mr. K.V.G.K. Raju has been associated with the Company since 18th May, 1992 and has been a strong force in heralding the Company to technological and quality excellence.

The Board of Directors of the Company and the entire Gland Pharma family places on record their deep sense of appreciation for the long-standing leadership and contribution of Mr. K.V.G.K. Raju to the success of the Company. Mr. K Raghuram Chandra Rao, currently serving as Vice president (Quality Assurance) shall take over as the Head-Quality of the Company and consequently, would become a Senior Management Personnel of the Company, with effect from 30th March, 2024. Mr. Raghuram has been associated with the Company since 1st December, 1999 and has overall experience of almost 25 years in Pharmaceutical industry.

Mr. Susheel Ogra would retire from the position of Asst. Vice President and Head of Domestic Marketing of the Company with effect from the close of business hours on 25th March, 2024 due to his superannuation. Accordingly, Mr. Susheel Ogra shall also cease to be Senior Management Personnel of the Company with effect from 26th March, 2024.

Mr. Surinder Koul, currently serving as General Manager (Domestic Marketing) shall assume the role of Head of Domestic Marketing of the Company and consequently would be categorized as a Senior Management Personnel of the Company with effect from 26th March, 2024. Mr. Prakash Vithal Baliga, Chief Operating Officer and SMP of the Company has tendered resignation to his office in the Company to pursue other interests and opportunities. The resignation was accepted and he would be relieved from his official duties from the closure of the business hours on 30th April, 2024 and consequently he shall cease to be the SMP of the Company with effect from 1st May, 2024.

Mr. K Raghuram Chandra Rao joined Gland Pharma Limited on 1st December, 1999 as an Executive in Quality Assurance and rose to the level of Vice-President. He has more than 25 years of experience in Quality Systems. Mr. Raghuram has been involved in developing and executing quality systems and designing the quality metrics to regulate the quality of medicines specifically in the area of parenteral formulations. He has also been involved in training and development of various aspects of quality systems. He is actively involved in Production Data Acquisition (PDA) in the knowledge sharing process.

Starting his career in academics and worked for two years before moving into the industry, Mr. Raghuram worked for brief stints with AstraZeneca and Dr. Reddy's Laboratories, prior to joining Gland Pharma. Mr. Surinder Koul joined Gland Pharma Limited in March, 2018 as National Sales Manager and rose to the level of General Manager. He has more than 26 years of experience in Marketing of Pharmaceutical products.

Mr. Surinder Koul started his career as a Medical Representative with ICPA Health Products and later worked with various organizations viz., Sarabhai Chemicals, Centaur Pharmaceuticals, Anglo French & Drugs, and Ozone Pharmaceuticals in different roles. Mr. Surinder Koul is a graduate from Kashmir University.